TOMM70A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.499200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.554600E-01
Normal-vs-Stage2
6.823200E-01
Normal-vs-Stage3
5.094600E-01
Normal-vs-Stage4
2.176600E-01
Stage1-vs-Stage2
2.015400E-01
Stage1-vs-Stage3
3.138300E-02
Stage1-vs-Stage4
5.266000E-01
Stage2-vs-Stage3
2.182800E-01
Stage2-vs-Stage4
6.914200E-02
Stage3-vs-Stage4
7.748100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.768400E-01
Normal-vs-AfricanAmerican
4.592400E-01
Normal-vs-Asian
8.403800E-01
Caucasian-vs-AfricanAmerican
3.890200E-01
Caucasian-vs-Asian
6.225400E-01
AfricanAmerican-vs-Asian
2.756000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.004800E-01
Normal-vs-Female
5.931400E-01
Male-vs-Female
5.736600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.096000E-01
Normal-vs-Age(41-60Yrs)
3.823000E-01
Normal-vs-Age(61-80Yrs)
8.224600E-01
Normal-vs-Age(81-100Yrs)
7.008400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.522200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.212800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.412000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.627670E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.326000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.647600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.690600E-01
Normal-vs-Daily Drinker
8.660200E-01
Normal-vs-Weekly Drinker
6.746600E-01
Normal-vs-Occasional Drinker
4.282800E-01
Normal-vs-Social Drinker
5.393800E-01
Non Drinker-vs-Daily Drinker
7.709800E-01
Non Drinker-vs-Weekly Drinker
4.929400E-01
Non Drinker-vs-Occasional Drinker
7.170300E-02
Non Drinker-vs-Social Drinker
1.867620E-01
Daily Drinker-vs-Weekly Drinker
6.969000E-01
Daily Drinker-vs-Occasional Drinker
1.563390E-01
Daily Drinker-vs-Social Drinker
3.224600E-01
Weekly Drinker-vs-Occasional Drinker
3.320600E-01
Weekly Drinker-vs-Social Drinker
5.488400E-01
Occasional Drinker-vs-Social Drinker
7.369800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.134800E-01
Normal-vs-Grade 2
5.602200E-02
Normal-vs-Grade 3
5.014100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.285160E-01
Grade 1-vs-Grade 3
8.891700E-02
Grade 1-vs-Grade 4
2.134800E-01
Grade 2-vs-Grade 3
6.162400E-01
Grade 2-vs-Grade 4
5.602200E-02
Grade 3-vs-Grade 4
5.014100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.512600E-01
Normal-vs-NonDiabetic
6.601800E-01
Diabetic-vs-NonDiabetic
2.535400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.024000E-01
Normal-vs-NoPancreatitis
7.051600E-01
Pancreatitis-vs-NoPancreatitis
8.488600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.736200E-01
Normal-vs-N1
6.669600E-01
N0-vs-N1
5.208800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.523400E-01
Normal-vs-TP53-NonMutant
5.377200E-01
TP53-Mutant-vs-TP53-NonMutant
9.917600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
